Tissue inhibitor of metalloproteinases-3 and sorsby fundus dystrophy

Advances in Experimental Medicine and Biology

Volumn 533, Issue , 2003, Pages 97-105

  Qi, Jian Hua ^a   Ebrahem, Quteba ^a   Anand Apte, Bela ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANGIOGENESIS; BRUCH MEMBRANE; CLINICAL FEATURE; CONFERENCE PAPER; ENZYME INHIBITION; ENZYME STRUCTURE; EYE; GENE MUTATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA DYSTROPHY; RETINA MACULA AGE RELATED DEGENERATION; SORSBY FUNDUS DYSTROPHY; SUBRETINAL NEOVASCULARIZATION;

EID: 0346896649     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0067-4_13     Document Type: Conference Paper

References (71)

1. Ahonen, M., R. Ala-Aho, A.H. Baker, S.J. George, R. Grenman, U. Saarialho-Kere, and V.M. Kahari. 2002. Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3. Mol Ther. 5:705-15.
2. Ahonen, M., A.H. Baker, and V.M. Kahari. 1998a. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58:2310-5.
3. Ahonen, M., A.H. Baker, and V.M. Kahari. 1998b. High level expression of tissue inhibitors of metalloproteinases-1,-2 and -3 in melanoma cells achieved by adenovirus mediated gene transfer. Adv Exp Med Biol. 451:69-72.
4. Alexander, C.M., and Z. Werb. 1992. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol. 118:727-39.
5. Amin, R., J.E. Puklin, and R.N. Frank. 1994. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 35:3178-88.
6. Anand-Apte, B., M.S. Pepper, E. Voest, R. Montesano, B. Olsen, G. Murphy, S.S. Apte, and B. Zetter. 1997. Inhibition of Angiogenesis by Tissue Inhibitor of Metalloproteinase-3. Invest. Ophthal Vis. Sci. 38:817-823.
7. Apte, S.S., B. Olsen, and G. Murphy. 1995. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270:14313-14318.
8. Baker, A.H., S.J. George, A.B. Zaltsman, G. Murphy, and A.C. Newby. 1999. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer. 79:1347-55.
9. Baker, A.H., A.B. Zaltsman, S.J. George, and A.C. Newby. 1998. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest. 101:1478-87.
10. Bird, A.C. 1992. Bruch's membrane change with age. Br J Ophthalmol. 76:166-8.
11. Bird, A.C. 1993. Choroidal neovascularisation in age-related macular disease [editorial]. Br J Ophthalmol. 77:614-5.
12. Bond, M., G. Murphy, M.R. Bennett, A. Amour, V. Knauper, A.C. Newby, and A.H. Baker. 2000. Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J Biol Chem. 275:41358-63.
13. Brooks, P.C. 1996. Cell adhesion molecules in angiogenesis. Cancer Metastasis Rev. 15:187-94.
14. Capon, M.R., J. Marshall, J.I. Krafft, R.A. Alexander, P.S. Hiscott, and A.C. Bird. 1989. Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology. 96:1769-77.
15. Capon, M.R., P.J. Polkinghorne, F.W. Fitzke, and A.C. Bird. 1988. Sorsby's pseudoinflammatory macula dystrophy - Sorsby's fundus dystrophies. Eye. 2:114-22.
16. Chong, N.H., R.A. Alexander, T. Gin, A.C. Bird, and P.J. Luthert. 2000. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci. 41:898-902.
17. D'Amore, P.A. 1994. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 35:3974-9.
18. Dastgheib, K., and W.R. Green. 1994. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol. 112:813-8.
19. Della, N.G., P.A. Campochiaro, and D.J. Zack. 1996. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 37:1921-4.
20. Fariss, R.N., S.S. Apte, P.J. Luthert, A.C. Bird, and A.H. Milam. 1998. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol. 82:1329-34.
21. Fariss, R.N., S.S. Apte, B.R. Olsen, K. Iwata, and A.H. Milam. 1997. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol. 150:323-8.
22. Fata, J.E., K.J. Leco, E.B. Voura, H.Y. Yu, P. Waterhouse, G. Murphy, R.A. Moorehead, and R. Khokha. 2001. Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest. 108:831-41.
23. Frank, R.N., R.H. Amin, D. Eliott, J.E. Puklin, and G.W. Abrams. 1996. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 122:393-403.
24. Gariano, R.F., R.E. Kalina, and A.E. Hendrickson. 1996. Normal and pathological mechanisms in retinal vascular development. Surv Ophthalmol. 40:481-90.
25. George, S.J., C.T. Lloyd, G.D. Angelini, A.C. Newby, and A.H. Baker. 2000. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation. 101:296-304.
26. Green, W.R., and C. Enger. 1993. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 100:1519-35.
27. Grunwald, J.E., S.M. Hariprasad, J. DuPont, M.G. Maguire, S.L. Fine, A.J. Brucker, A.M. Maguire, and A.C. Ho. 1998. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 39:385-90.
28. Hamilton, W.K., C.C. Ewing, E.J. Ives, and J.D. Carruthers. 1989. Sorsby's fundus dystrophy. Ophthalmology. 96:1755-62.
29. Hiraoka, N., E. Allen, I.J. Apel, M.R. Gyetko, and S.J. Weiss. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:365-77.
30. Hoskin, A., K. Sehmi, and A.C. Bird. 1981. Sorsby's pseudoinflammatory macular dystrophy. Br J Ophthalmol. 65:859-65.
31. Itoh, T., M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, S. Itohara, P. Hofman, B.C. van Blijswijk, P.J. Gaillard, G.F. Vrensen, and R.O. Schlingemann. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1048-51.
32. Jacobson, S.G., A.V. Cideciyan, G. Regunath, F.J. Rodriguez, K. Vandenburgh, V.C. Sheffield, and E.M. Stone. 1995. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat Genet, 11:27-32.
33. Kamei, M., S.S. Apte, M.E. Rayborn, H. Lewis, and J.G. Hollyfield. 1997. TIMP-3 accumulation in drusen and Bruch's membrane in eyes from donors with age-related macular degeneration (1997). In Degenerative Diseases of the Retina. M.M. Luvail, R.E. Anderson, and J.G. Hollyfield, editors. Plenum Press, New York. 11-15.
34. Kamei, M., and J. Hollyfield. 1999. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci. 40: p2367-75.
35. Killingsworth, M.C., J.P. Sarks, and S.H. Sarks. 1990. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye. 4:613-21.
36. Kvanta, A., P.V. Algvere, L. Berglin, and S. Seregard. 1996. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 37:1929-34.
37. Langton, K.P., M.D. Barker, and N. McKie. 1998. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J Biol Chem. 273:16778-81.
38. Langton, K.P., N. McKie, A. Curtis, J.A. Goodship, P.M. Bond, M.D. Barker, and M. Clarke. 2000. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J Biol Chem. 275:27027-31.
39. Leco, K.J., P. Waterhouse, O.H. Sanchez, K.L. Gowing, A.R. Poole, A, Wakeham, T.W. Mak, and R. Khokha. 2001. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest. 108:817-829.
40. Lopez, P.F., B.D. Sippy, H.M. Lambert, A.B. Thach, and D.R. Hinton. 1996. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 37:855-68.
41. Matrisian, L.M. 1992. The matrix-degrading metalloproteinases. Bioessays. 14:455-63.
42. Murphy, G. 1991. The regulation of connective tissue metalloproteinases by natural inhibitors. In AAS 35: Progress in Inflammation Research and Therapy. Birkhauser, Basel. 69-76.
43. Nguyen, Q., F. Willenbrock, M.I. Cockett, M. O'Shea, A.J. Docherty, and G. Murphy. 1994. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A. Biochemistry. 33:2089-95.
44. Ogata, N., M. Matsushima, Y. Takada, T. Tobe, K. Takahashi, X. Yi, C. Yamamoto, H. Yamada, and M. Uyama. 1996. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. Curr Eye Res. 15:1008-18.
45. Polkinghorne, P.J., M.R. Capon, T. Berninger, A.L. Lyness, K. Sehmi, and A.C. Bird. 1989a. Sorsby's fundus dystrophy. A clinical study. Ophthalmology. 96:1763-8.
46. Polkinghorne, P.J., M.R.C. Capon, T. Berninger, A.L. Lyness, K. Sehmi, and A.C. Bird. 1989b. Sorsby's fundus dystrophy. A clinical study. Ophthalmol. 96:1763-1768.
47. Qi, J.H., Q. Ebrahem, K. Yeow, D.R. Edwards, P.L. Fox, and B. Anand-Apte. 2002. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment Epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis. J Biol Chem. 30:30.
48. Ross, R.D., J.M. Barofsky, G. Cohen, W.B. Baber, S.W. Palao, and K.A. Gitter. 1998. Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration. Am J Ophthalmol. 125:71-80.
49. Ruiz, A., P. Brett, and D. Bok. 1996a. TIMP-3 is expressed in the human retinal pigment epithelium. Biochem Biophys Res Commun. 226: p467-74.
50. Ruiz, A., B. Peterson, and D. Bok. 1996b. Localization and quantification of TIMP-3 mRNA in the human retina. Invest. Ophthalmol. Vis, Sci. 37:S1143.
51. Sakamoto, T., H. Sakamoto, T.L. Murphy, C. Spee, D. Soriano, T. Ishibashi, D.R. Hinton, and S.J. Ryan. 1995. Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells. Arch Ophthalmol. 113:512-20.
52. Sorsby, A., and M.E. Joll Mason. 1949. A fundus dystrophy with unusual features. British journal of Ophthalmology:61-97.
53. Soubrane, G., S.Y. Cohen, T. Delayre, J. Tassin, M.P. Hartmann, G.J. Coscas, Y. Courtois, and J.C. Jeanny. 1994. Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig. Curr Eye Res. 13:183-95.
54. Stetler-Stevenson, W.G. 2001. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am. 10:383-92, x.
55. Stetler-Stevenson, W.G., and A.E. Yu. 2001. Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol. 11:143-52.
56. Tabata, Y., Y. Isashiki, K. Kamimura, K. Nakao, and N. Ohba. 1998. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features. Hum Genet. 103:179-82.
57. Vranka, J.A., A. Shepardson, E.G. johnson, X.-H. Zhu, J.P. Alexander, and J.M.B. Bradley. 1996. TIMP3 expression in the human retina and choroid. Invest. Ophthalmol. Vis. Sci. 15:S273.
58. Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior, and Z. Werb. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:411-22.
59. Weber, B.H., B. Lin, K. White, K. Kohler, G. Soboleva, S. Herterich, M.W. Seeliger, G.B. Jaissle, C. Grimm, C. Reme, A. Wenzel, E. Asan, and H. Schrewe. 2002. A mouse model for Sorsby fundus dystrophy. Invest Ophthalmol Vis Sci. 43:2732-40.
60. Weber, B.H., G. Vogt, R.C. Pruett, H. Stohr, and U. Felbor. 1994. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet. 8:352-6.
61. Werb, Z., T.H. Vu, J.L. Rinkenberger, and L.M. Coussens. 1999. Matrix-degrading proteases and angiogenesis during development and tumor formation. Apmis. 107:11-8.
62. Willenbrock, F., T. Crabbe, P.M. Slocombe, C.W. Sutton, A.J. Docherty, M.I. Cockett, M. O'Shea, K. Brocklehurst, I.R. Phillips, and G. Murphy. 1993. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry. 32:4330-7.
63. Williamson, R.A., F.A. Marston, S. Angal, P. Koklitis, M. Panico, H.R. Morris, A.F. Came, B.J. Smith, T.J. Harris, and R.B. Freedman. 1990. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J. 268:267-74.
64. Woessner, J.F., Jr. 2001. That impish TIMP: the tissue inhibitor of metalloproteinases-3. J Clin Invest. 108:799-800.
65. Wu, G., R.C. Pruett, J. Baldinger, and T. Hirose. 1991. Hereditary hemorrhagic macular dystrophy. Am J Ophthalmol. 111:294-301.
66. Xu, J., D. Rodriguez, E. Petitclerc, J.J. Kim, M. Hangai, S.M. Yuen, G.E. Davis, and P.C. Brooks. 2001. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 154:1069-80.
67. Yeow, K.M., N.S. Kishnani, M. Hutton, S.P. Hawkes, G. Murphy, and D.R. Edwards. 2001. Sorsby's fundus dystrophy Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities but affect cell adhesion to the extracellular matrix. Matrix Biology. In Press.
68. Yi, X., N. Ogata, M. Komada, C. Yamamoto, K. Takahashi, K. Omori, and M. Uyama. 1997. Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol. 235:313-9.
69. Zack, D.J., M. Dean, R.S. Molday, J. Nathans, T.M. Redmond, E.M. Stone, A. Swaroop, D. Valle, and B.H. Weber. 1999. What can we learn about age-related macular degeneration from other retinal diseases? Mol Vis. 5:30.
70. Zucker, S. 1996. Correspondence re: N-B. Liabakk et al., matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res., 56: 190-196, 1966 [letter]. Cancer Res. 56:3610.